Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Passage BIO, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +6 vs. Q4 2025
- Shares held
- 1.78M
- +329.3K (+22.7%) vs. Q4 2025
- Total value
- $13.8M
- −$3.29M (−19.2%) vs. Q4 2025
- New holders
- 12
- 6 more added
- Sold out
- 6
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TSFG, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| CWM, LLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 3 | $24 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $93 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $94 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 12 | $94 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 15 | $117 | 0.00% | −5−25.0% | Reduced |
| Parallel Advisors, LLC | 16 | $126 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 115 | $903 | 0.00% | +115 | New |
| SBI Securities Co., Ltd. | 124 | $973 | 0.00% | −18−12.7% | Reduced |
| Barclays PLC | 212 | $1.66K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 502 | $3.94K | 0.00% | +502 | New |
| Vanguard Global Advisers, LLC | 638 | $5.01K | 0.00% | +638 | New |
| Rockefeller Capital Management L.P. | 800 | $6.28K | 0.00% | +300+60.0% | Added |
| Morgan Stanley | 2,650 | $20.8K | 0.00% | −1,625−38.0% | Reduced |
| Persistent Asset Partners Ltd | 4,955 | $38.9K | 0.02% | +4,955 | New |
| Fiduciary Trust Co | 10,750 | $84.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 12,627 | $99.1K | 0.00% | +12,627 | New |
| Vanguard Fiduciary Trust Co | 17,049 | $133.8K | 0.00% | +17,049 | New |
| Boothbay Fund Management, LLC | 18,871 | $148.1K | 0.00% | +18,871 | New |
| Diadema Partners LP | 19,530 | $153.3K | 0.06% | +19,530 | New |
| Verdad Advisers, LP | 22,128 | $173.7K | 0.20% | +22,128 | New |
| Acadian Asset Management LLC | 24,196 | $189.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 27,501 | $215.9K | 0.00% | +26,059+1,807.1% | Added |
| BlackRock, Inc. | 28,595 | $224.5K | 0.00% | −308−1.1% | Reduced |
| Geode Capital Management, LLC | 41,380 | $324.9K | 0.00% | +9,983+31.8% | Added |
| Erste Asset Management GmbH | 85,262 | $526.9K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 68,124 | $534.8K | 0.08% | +68,124 | New |
| Yiheng Capital Management, L.P. | 86,097 | $675.9K | 0.29% | +51,796+151.0% | Added |
| Vanguard Capital Management LLC | 113,964 | $894.6K | 0.00% | +113,964 | New |
| Eversept Partners, LP | 131,581 | $1.03M | 0.07% | +5,351+4.2% | Added |
| Renaissance Technologies LLC | 133,612 | $1.05M | 0.00% | +24,523+22.5% | Added |
| Vestal Point Capital, LP | 305,000 | $2.39M | 0.07% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 623,704 | $4.90M | 0.77% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,660−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −14,217−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −12,578−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,799−100.0% | Sold out |
| Nano Cap New Millennium Growth Fund L P | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |